Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• ErbB3 receptor tyrosine kinase overexpression drives tumor progression and therapeutic resistance.
• Loss of negative regulatory mechanisms, like protein degradation, contributes to ErbB3 overexpression.
• Nrdp1, an E3 ubiquitin ligase, normally suppresses ErbB3 levels by promoting its degradation.

Purpose of the Study:

• To elucidate the mechanism by which Nrdp1 regulates ErbB3 levels.
• To investigate the role of the endoplasmic reticulum (ER) and ER-associated degradation (ERAD) pathway in Nrdp1-mediated ErbB3 regulation.

Main Methods:

• Co-localization studies of Nrdp1 and ErbB3 at the ER.
• Assessment of Nrdp1's effect on ErbB3 ubiquitination and degradation under conditions of ER exit blockade.
• Investigation of the role of VCP/p97 ATPase in the ERAD pathway concerning Nrdp1-mediated ErbB3 degradation.

Main Results:

• Nrdp1 preferentially binds to nascent ErbB3 at the ER, accelerating its degradation.
• Nrdp1 mediates ErbB3 ubiquitination and degradation independently of ER exit.
• Disruption of the ERAD pathway component VCP/p97 leads to accumulation of ubiquitinated ErbB3 but inhibits its degradation.
• Nrdp1 targets properly folded, functional ErbB3 for degradation.

Conclusions:

• Nrdp1 regulates ErbB3 levels through an ER-localized degradation pathway.
• This pathway controls the quantity of signaling-competent ErbB3, offering potential therapeutic targets.
• The findings reveal a novel mechanism for receptor tyrosine kinase quantity control.